MA42891B2 - Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor - Google Patents
Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptorInfo
- Publication number
- MA42891B2 MA42891B2 MA42891A MA42891A MA42891B2 MA 42891 B2 MA42891 B2 MA 42891B2 MA 42891 A MA42891 A MA 42891A MA 42891 A MA42891 A MA 42891A MA 42891 B2 MA42891 B2 MA 42891B2
- Authority
- MA
- Morocco
- Prior art keywords
- glp
- glucagon
- gip receptor
- persistent conjugate
- triple activator
- Prior art date
Links
Abstract
La présente invention concerne un conjugué persistant d'un triple activateur qui active le récepteur du glucagon, du glp-1 et du gip, et des applications du conjugué persistant.The present invention relates to a persistent conjugate of a triple activator which activates the glucagon, glp-1 and gip receptor, and applications of the persistent conjugate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20150191082 | 2015-12-31 | ||
PCT/KR2016/015555 WO2017116205A1 (en) | 2015-12-31 | 2016-12-30 | Persistent conjugate of triple activator activating glucagon, glp-1 and gip receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
MA42891A1 MA42891A1 (en) | 2019-04-30 |
MA42891B2 true MA42891B2 (en) | 2021-11-30 |
Family
ID=62104015
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42889A MA42889B2 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating the glucagon, glp-1 and gip receptor |
MA42891A MA42891B2 (en) | 2015-12-31 | 2016-12-30 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
MA51955A MA51955B1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
MA53533A MA53533A1 (en) | 2015-12-31 | 2018-07-26 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA42889A MA42889B2 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating the glucagon, glp-1 and gip receptor |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA51955A MA51955B1 (en) | 2015-12-31 | 2016-12-30 | Triple activator activating glucagon, glp-1 and gip receptor |
MA53533A MA53533A1 (en) | 2015-12-31 | 2018-07-26 | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor |
Country Status (3)
Country | Link |
---|---|
AR (2) | AR107281A1 (en) |
MA (4) | MA42889B2 (en) |
MY (1) | MY199261A (en) |
-
2016
- 2016-12-30 MA MA42889A patent/MA42889B2/en unknown
- 2016-12-30 MY MYPI2018001199A patent/MY199261A/en unknown
- 2016-12-30 MA MA42891A patent/MA42891B2/en unknown
- 2016-12-30 MA MA51955A patent/MA51955B1/en unknown
-
2017
- 2017-01-02 AR ARP170100003A patent/AR107281A1/en unknown
- 2017-01-02 AR ARP170100004A patent/AR107282A1/en unknown
-
2018
- 2018-07-26 MA MA53533A patent/MA53533A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR107282A1 (en) | 2018-04-18 |
MY199261A (en) | 2023-10-23 |
MA51955A1 (en) | 2021-10-29 |
MA42889B2 (en) | 2020-11-30 |
MA42891A1 (en) | 2019-04-30 |
AR107281A1 (en) | 2018-04-18 |
MA51955B1 (en) | 2022-04-29 |
MA53533A1 (en) | 2022-08-31 |
MA42889A1 (en) | 2018-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018008128A (en) | Persistent conjugate of triple activator activating glucagon, glp-1 and gip receptor. | |
CL2023001910A1 (en) | Glucagon derivative and a composition comprising a long-acting conjugate thereof | |
MA43187A (en) | SUBCUTANEOUS ANTI-CD38 ANTIBODY FORMULATIONS AND THEIR USES | |
MX2020003217A (en) | Long-acting co-agonists of the glucagon and glp-1 receptors. | |
MX2020005483A (en) | Ildr2 antagonists and combinations thereof. | |
WO2017074798A3 (en) | Long-acting co-agonists of the glucagon and glp-1 receptors | |
TR201901516T4 (en) | Neuroprotective agents and their uses. | |
CL2019003037A1 (en) | Fungicidal combinations. | |
MA53533A1 (en) | Persistent conjugate of a triple activator activating the glucagon, glp-1 and gip receptor | |
EA201691422A1 (en) | ORIGINALLY FALLING TABLETED MEMANTINE COMPOSITIONS | |
UA120448U (en) | FUNGICID COMPOSITION | |
EA201992475A1 (en) | COMBINATION CONTAINING SUCH A PPAR AGONIST AS ELAFIBRANOR AND ACETYL-COA-CARBOXYLASE (ACC) INHIBITOR | |
UA120068C2 (en) | FUNGICIDAL COMPOSITION | |
UA114469U (en) | APPLICATION OF CAPICOR PREPARATION (MELDONIA DIGITRATE AND γ-BUTYROBETAINE DIGITRATE) AS A NEPHROPROTECTOR | |
EA201991993A1 (en) | APPLICATION OF PHENYLCREATIN AS A NOOTROPIC AGENT | |
UA108342U (en) | 7-N-BUTYL-8-N, N-DIETHYLAMINOETHYLAMIN-3-METHYLXANTINE SUCCINATE, WHICH HAS DIURETIC AND ANALGETIC ACTION | |
UA100710U (en) | APPLICATION OF FITOVENOL Capsules AS A HEPATOPROTECTOR | |
MA39074B1 (en) | Combination therapy with an anti-ang 2 antibody and a cd40 agonist | |
RU2013145736A (en) | FUSION COMPOSITION FOR EMULSION FLEGMATIZATION OF POWDERS |